Cyclodextrin slows NPC progression in new Washington University trial

A new clinical trial conducted by Washington University School of Medicine in St Louis and the National Institutes of Health (NIH) in the US has shown that a drug called cyclodextrin slows progression of Niemann-Pick type C (NPC) disease.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news